PETER ANDERSON: Open Payments
NPI 1144337916 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,869 in 97 payments from 17 companies in 2025. Trend: 2023 $733 · 2024 $1,335 · 2025 $1,869
Food & beverage: $1,852Education: $18
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $449 |
| Amgen Inc. | 10 | $229 |
| ViiV Healthcare Company | 8 | $189 |
| Insmed, Inc. | 11 | $174 |
| Gilead Sciences, Inc. | 11 | $166 |
| Melinta Therapeutics, LLC | 13 | $140 |
| Aimmune Therapeutics, Inc. | 5 | $103 |
| UCB, Inc. | 4 | $65 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| Janssen Biotech, Inc. | 2 | $52 |
Products named: Arikayce, EVENITY, DALVANCE, Rezzayo, MAVYRET, CABENUVA, VOWST, RINVOQ.
Industry payments across OR — which companies pay providers there.
